Annovis Bio, Inc. SEC filings ANVS
Annovis Bio, Inc. has 312 filings in SEC EDGAR's recent list, going back to Jan 15, 2010. Its latest annual report, Form 10-K, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 4, 2026 | — |
| 424B5 | Prospectus supplement | May 20, 2026 | — |
| 424B5 | Prospectus supplement | May 19, 2026 | — |
| 424B5 | Prospectus supplement | Apr 9, 2026 | — |
| 424B5 | Prospectus supplement | Oct 28, 2025 | — |
| 424B5 | Prospectus supplement | Oct 14, 2025 | — |
| 424B5 | Prospectus supplement | Feb 4, 2025 | — |
| 424B5 | Prospectus supplement | Feb 3, 2025 | — |
| 424B5 | Prospectus supplement | Dec 11, 2024 | — |
| S-8 | Employee stock plan registration | Jun 21, 2024 | — |
| 424B5 | Prospectus supplement | May 1, 2024 | — |
| 424B5 | Prospectus supplement | Mar 22, 2024 | — |
| 424B5 | Prospectus supplement | Mar 19, 2024 | — |
| 424B5 | Prospectus supplement | Mar 19, 2024 | — |
| S-3/A | Filing | Feb 12, 2024 | — |
| S-3 | Shelf registration | Feb 1, 2024 | — |
| 424B5 | Prospectus supplement | Nov 1, 2023 | — |
| 424B5 | Prospectus supplement | Oct 30, 2023 | — |
| 424B5 | Prospectus supplement | Mar 31, 2023 | — |
| 424B4 | Prospectus | May 24, 2021 | — |
| FWP | Free writing prospectus | May 21, 2021 | — |
| 424B4 | Prospectus | May 21, 2021 | — |
| S-3 | Shelf registration | Feb 1, 2021 | — |
| S-8 | Employee stock plan registration | Feb 14, 2020 | — |
| 424B4 | Prospectus | Jan 30, 2020 | — |
| S-1MEF | Filing | Jan 29, 2020 | — |
| S-1/A | Amended registration statement | Jan 24, 2020 | — |
| S-1/A | Amended registration statement | Jan 21, 2020 | — |
| FWP | Free writing prospectus | Dec 10, 2019 | — |
| S-1/A | Amended registration statement | Nov 19, 2019 | — |
| S-1/A | Amended registration statement | Sep 20, 2019 | — |
| S-1/A | Amended registration statement | Aug 28, 2019 | — |
| S-1/A | Amended registration statement | Aug 8, 2019 | — |
| S-1 | Registration statement | Jul 3, 2019 | — |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANVS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Malvern, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1477845
- Former names
- QR Pharma, Inc. (until Mar 15, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.